The authors reply

New England Journal of Medicine

Volumn 372, Issue 10, 2015, Pages 980-981

  Lacro, Ronald V ^a   Dietz, Harry C ^b   Mahony, Lynn ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; LOSARTAN; PLACEBO; TRANSFORMING GROWTH FACTOR BETA; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGE; AORTA ANEURYSM; AORTA DISEASE; AORTA DISSECTION; AORTA VALVE REGURGITATION; ASCENDING AORTA; CLINICAL EVALUATION; COMPARATIVE EFFECTIVENESS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; FOLLOW UP; HEART RATE; HUMAN; LETTER; MARFAN SYNDROME; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; AORTA; AORTIC ANEURYSM; DRUG EFFECTS; FEMALE; MALE;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; AORTA; AORTIC ANEURYSM; ATENOLOL; FEMALE; HUMANS; LOSARTAN; MALE; MARFAN SYNDROME;

EID: 84924485481     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1500128     Document Type: Letter

References (4)

1. Lindsay ME, Dietz HC. The genetic basis of aortic aneurysm. Cold Spring Harb Perspect Med 2014;4: a015909.
2. Wang Y, Ait-Oufella H, Herbin O, et al. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest 2010; 120: 422-32.
3. Li W, Li Q, Jiao Y, et al. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Invest 2014;124: 755-67.
4. Dietz HC. TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J Clin Invest 2010; 120: 403-7.